To see a world cured of DADA2.
The DADA2 Foundation aims to find innovative ways for patients & families, physicians, researchers, non-profits, government, academia, biotech and pharma, to work together to accelerate research into the rare disease Deficiency of Adenosine Deaminase 2, to raise awareness about the condition, and to improve the lives of DADA2 patients around the world.
We feel that establishing our large network of patients and families, physicians and researches is the secret sauce to moving fast as possible toward a cure for DADA2 and improving the lives of DADA2 patients around the world.
Key tenets to our strategy today include:
Most recently, we published the Foundation's first-ever Momentum Report, which outlines our goals for 2022 and 2023. We are thrilled to report that several of these initiatives are either complete or well underway.
The DADA2 Foundation, like so many patient-driven rare disease organizations, is the result of two passionate parents searching for a cure for their children. In Nashville, Tennessee, U.S.A, the Chambers family had pursued an answer to their first child's symptoms which persisted for nearly 15 years, only to be followed by their second child beginning to show signs. Doctors and specialists could not determine the cause until two papers were published in 2014 in the New England Journal of Medicine. A post on a closed blog for immunologists caused one doctor from Finland to contact the family and propose DADA2 as the possible answer. Armed with this isight and the two journal articles, the diagnosis was made within months. Their persistence focused on their two children set off a chain reaction that eventually left to the establishment of the DADA2 Foundation.
The timeline below tells the story of gatherings publications, accomplishments, and what we're looking forward to. You can also watch the video at the end of the timeline or download a PDF of this history.